porcin
respiratori
reproduct
syndrom
prr
econom
import
diseas
pig
worldwid
current
use
prrsv
vaccin
provid
incomplet
protect
recent
identifi
mycobacterium
tuberculosi
whole
cell
lysat
mtb
wcl
potent
mucos
adjuv
modifi
live
prrsv
vaccin
prrsmlv
studi
pig
unvaccin
vaccin
prrsmlv
plu
mtb
wcl
intranas
challeng
either
homolog
strain
virul
heterolog
strain
prrsv
subsequ
euthan
three
time
point
postchalleng
evalu
lung
immun
respons
microscop
examin
lung
section
reveal
reduc
disrupt
lung
architectur
less
interstiti
pneumonia
vaccin
compar
unvaccin
challeng
pig
restimul
lung
peripher
blood
mononuclear
cell
reveal
increas
prolifer
lymphocyt
lung
homogen
increas
secret
nitric
oxid
detect
vaccin
challeng
pig
summari
adjuv
effect
mtb
wcl
prrsmlv
result
favor
antiprrsv
immun
microenviron
lung
help
better
viral
clearanc
p
orcin
reproduct
respiratori
syndrom
prr
devast
problem
plagu
global
swine
industri
within
last
two
decad
annual
econom
loss
due
prr
estim
million
us
prr
character
respiratori
reproduct
abnorm
major
loss
reproduct
failur
associ
stillbirth
mummif
weak
born
piglet
high
prewean
mortal
respiratori
form
lead
pneumonia
reduc
feed
intak
chronic
recur
ill
debilit
potenti
high
mortal
caus
agent
prr
viru
prrsv
arteriviru
posit
sens
rna
genom
prrsv
prone
constant
genet
antigen
variat
base
genet
divers
prrsv
divid
two
genotyp
european
type
north
american
strain
lelystad
refer
prototyp
strain
type
type
prrsv
respect
prrsv
replic
alveolar
macrophag
persist
day
lymphoid
tissu
porcin
immun
system
unabl
mount
effect
antiprrsv
immun
respons
first
week
postinfect
attribut
dampen
product
antivir
cytokin
viru
neutral
antibodi
cellmedi
immun
respons
addit
immunosuppress
caus
viru
make
infect
pig
prone
secondari
bacteri
viral
infect
control
prr
outbreak
commonli
employ
vaccin
includ
modifi
live
prrsv
prrsmlv
kill
viru
vaccin
kill
vaccin
provid
adequ
protect
prrsmlv
provid
satisfactori
protect
homolog
infect
protect
heterolog
virus
reinfect
incomplet
report
result
obtain
use
field
isol
prrsv
prrsmlv
administ
either
parenter
intranas
rout
show
suppress
innat
nk
cell
cytotox
function
ifna
product
weak
delay
cellmedi
viru
neutral
antibodi
respons
associ
prolong
immunosuppress
improv
efficaci
prrsmlv
pig
explor
benefit
induc
antiprrsv
mucos
immun
intranas
coadministr
prrsmlv
suitabl
mucos
adjuv
intranas
immun
certain
vaccin
shown
great
promis
elicit
protect
immun
variou
respiratori
viral
infect
bovin
herp
influenza
mucos
tissu
associ
lymphoid
organ
contain
approxim
total
immun
cell
bodi
stimul
mucos
immun
system
lead
gener
system
mucos
immun
respons
result
effect
prevent
entri
establish
pathogen
recent
demonstr
intranas
coadministr
prrsmlv
adjuv
mycobacterium
tuberculosi
whole
cell
lysat
mtb
wcl
overcom
vaccin
induc
immunosuppress
concomit
increas
host
innat
adapt
immun
respons
associ
better
protect
virul
heterolog
prrsv
challeng
also
shown
protect
antiprrsv
immun
respons
elicit
pig
prrsmlv
mediat
adjuv
effect
mtb
wcl
pig
vaccin
prrsmlv
fail
elicit
adequ
immun
respons
continu
articl
deal
aspect
microscop
lung
patholog
prolifer
prrsv
specif
lymphocyt
product
import
innat
molecul
nitric
oxid
lung
pig
vaccin
prrsmlv
mtb
wcl
challeng
prrsv
convent
larg
whiteduroc
crossbr
specificpathogenfre
piglet
wean
week
age
obtain
farm
regularli
screen
free
prrsv
porcin
respiratori
coronaviru
transmiss
gastroenter
viru
porcin
circoviru
type
use
studi
begin
studi
pig
test
confirm
absenc
prrsv
antibodi
elisa
throughout
durat
studi
pig
receiv
food
water
ad
libitum
inocul
includ
prrsv
challeng
perform
intranas
deliveri
anim
maintain
sampl
collect
euthan
larg
anim
facil
per
protocol
approv
institut
anim
care
use
committe
iacuc
institut
biosafeti
committe
ibc
ohio
state
univers
ohio
forti
pig
alloc
one
five
group
group
mock
pig
n
inocul
vehicl
normal
salin
dmem
four
group
n
per
group
group
unvaccin
group
vaccin
prrsmlv
boehring
ingelheim
vetmedica
inc
mtb
wcl
group
challeng
homolog
parenter
prrsv
strain
tcid
per
pig
group
challeng
virul
heterolog
prrsv
tcid
per
pig
ml
day
postimmun
nine
pig
group
euthan
three
time
point
day
postchalleng
dpc
n
per
group
mock
inocul
pig
n
euthan
togeth
prior
euthan
viru
challeng
anim
lung
tissu
sampl
collect
pig
fix
neutral
buffer
formalin
process
paraffin
block
three
lm
section
cut
stain
haematoxylin
eosin
describ
previous
lung
section
examin
blindfold
fashion
board
certifi
veterinari
pathologist
determin
lung
lesion
score
virusinduc
patholog
determin
prrsv
specif
prolifer
lymphocyt
lung
mononuclear
cell
lmnc
peripher
blood
mononuclear
cell
pbmc
isol
describ
cell
stain
irrevers
cytosol
dye
carboxyfluorescein
diacet
succinimidyl
ester
cfse
describ
previous
briefli
five
million
cell
wash
stain
cfse
lm
concentr
pb
incub
min
room
temperatur
label
reaction
stop
use
icecold
rpmi
contain
fb
wash
twice
resuspend
medium
incub
min
adjust
cell
number
cell
per
well
flat
bottom
plate
cell
restimul
semipurifi
prrsv
antigen
lgml
strain
obtain
ultracentrifug
clarifi
prrsv
infect
marc
cell
cultur
supernat
cell
untreat
treat
concavalin
use
neg
posit
control
respect
follow
day
incub
cell
wash
stain
rphycoerythrin
conjug
antipig
antibodi
clone
bd
bioscienc
final
cell
fix
event
acquir
use
fac
ariaii
bd
bioscienc
flow
cytomet
analyz
cfse
pe
stain
lymphocyt
cell
prolifer
data
analyz
flowjo
softwar
tree
star
inc
obtain
prolifer
index
pi
sampl
pi
denot
averag
number
cell
divis
respond
lymphocyt
underw
subtract
background
initi
popul
cell
gener
nitric
oxid
product
lung
determin
measur
nitrit
level
form
nitric
oxid
breakdown
product
use
commerci
kit
promega
lung
homogen
prepar
lung
tissu
sampl
describ
previous
sampl
treat
sulfanilamid
solut
min
dark
subsequ
dihydrochlorid
ned
solut
result
reaction
product
measur
absorb
nm
absorb
calcul
gener
nitrit
standard
refer
curv
data
express
mean
sem
three
pig
statist
analys
perform
use
twosampl
ttest
establish
differ
vaccin
unvaccin
group
statist
signific
assess
p
porcin
reproduct
respiratori
syndrom
viru
evolv
major
swine
diseas
last
decad
recent
demonstr
benefit
intranas
deliveri
prrsmlv
potent
mucos
adjuv
mtb
wcl
stimul
favor
antiprrsv
immun
respons
virul
heterolog
prrsv
potent
mucos
adjuv
use
mechan
lyze
endotoxinfre
wcl
mtb
contain
predominantli
solubl
intracellular
bacteri
protein
almost
free
toxic
cell
wall
lipid
compon
torrel
jb
person
commun
clinic
pig
administ
mtb
wcl
show
sign
side
effect
vaccin
prrsmlv
plu
mtb
wcl
pig
reduc
gross
lung
patholog
significantli
reduc
viremia
attribut
adjuv
mediat
innat
prrsv
specif
adapt
immun
respons
set
pig
provid
addit
import
inform
lung
microenviron
refer
statu
prrsv
specif
lymphocyt
nitric
oxid
product
microscop
lung
patholog
histolog
examin
reveal
reduc
lung
lesion
fig
indic
reduc
infiltr
mononuclear
cell
interstiti
pneumon
chang
vaccin
compar
unvaccin
challeng
pig
fig
vaccin
challeng
pig
reduc
although
statist
signific
trend
lung
lesion
score
detect
dpc
compar
unvaccin
pig
fig
due
low
virul
natur
strain
inflammatori
chang
lung
lesser
compar
challeng
pig
fig
bii
cellmedi
immun
viru
infect
contribut
differ
lymphocyt
subset
particular
contribut
significantli
cytotox
lymphocyt
ctl
activ
thmemori
cell
prrsvspecif
lymphocyt
present
pbmc
infect
pig
prolifer
postinfect
howev
far
knowledg
relat
statu
lymphocyt
lung
prrsv
infect
andor
vaccin
pig
limit
sinc
prrsv
replic
lung
infect
pig
inform
import
studi
increas
prolifer
total
prrsvspecif
lymphocyt
lung
lmnc
blood
pbmc
vaccin
compar
unvaccin
either
prrsv
strain
challeng
pig
detect
fig
data
shown
significantli
increas
prolifer
lymphocyt
pbmc
challeng
lmnc
challeng
pig
restimul
antigen
detect
fig
cii
ciii
pig
apart
cell
lymphocyt
abundantli
present
possess
memori
activ
thelper
cytolyt
properti
sinc
antigenspecif
prolifer
occur
cell
result
indic
prrsvspecif
prolifer
occur
lymphocyt
nitric
oxid
import
immun
molecul
involv
innat
adapt
immun
help
clearanc
intracellular
pathogen
inhibit
viral
replic
play
major
role
lung
immun
viru
clearanc
shown
inhibit
replic
influenza
viru
herp
simplex
viru
larg
amount
pulmonari
produc
epitheli
lung
induc
nitric
oxid
synthas
act
larginin
produc
determin
product
pig
lung
lung
homogen
repres
lung
parenchyma
prepar
use
analys
signific
increas
product
lung
pig
receiv
adjuv
vaccin
challeng
virul
prrsv
dpc
detect
fig
level
product
prrsmlv
alon
vaccin
challeng
pig
high
compar
unvaccin
viru
challeng
anim
dpc
data
shown
lung
pig
vaccin
challeng
strain
opposit
trend
product
detect
dpc
dpc
level
compar
group
fig
could
due
differenti
immun
respons
elicit
avirul
strain
earlier
report
demonstr
absenc
bronchoalveolar
lavag
fluid
mild
prrsv
strain
infect
pig
product
induc
nitric
oxid
synthetas
ino
alveolar
macrophag
howev
pulmonari
epitheli
cell
respiratori
viral
infect
contribut
significantli
product
studi
use
lung
homogen
pig
vaccin
prrsmlv
plu
mtb
wcl
challeng
virul
heterolog
prrsv
strain
significantli
increas
product
detect
lung
homogen
earlier
shown
increas
secret
reactiv
oxygen
speci
ro
bronchoalveolar
lavag
fluid
cell
pbmc
unvaccin
compar
vaccin
prrsmlv
plu
mtb
wcl
challeng
pig
three
dpc
ro
reactiv
nitrogen
speci
rn
need
antimicrobi
activ
overproduct
lead
bystand
cell
death
inflamm
tissu
injuri
one
rn
react
oxygen
radic
lead
product
ro
rn
balanc
ro
influenc
outcom
thu
possibl
prrsmlv
plu
mtb
wcl
euthan
dpc
pbmc
first
gate
cell
immunostain
rphycoerythrineconjug
pig
specif
antibodi
analyz
cfse
dilut
dye
cfse
indic
higher
prolifer
cell
c
prrsv
specif
lymphocyt
prolifer
data
shown
pig
unvaccin
vaccin
challeng
describ
euthan
dpc
iii
lmnc
ii
iv
pbmc
stain
cfse
subject
either
stimul
ag
restimul
indic
strain
kill
prrsv
antigen
bar
repres
averag
prolifer
index
lymphocyt
three
pig
sem
asterisk
denot
statist
signific
differ
p
unvaccin
vaccin
pig
vaccin
optim
increas
level
lung
virul
challeng
howev
lead
lung
injuri
rather
help
better
antiprrsv
immun
respons
compar
control
pig
conclus
intranas
coadministr
prrsmlv
mtb
wcl
elicit
favor
immun
respons
virul
heterolog
prrsv
challeng
indic
reduc
gross
lung
patholog
earli
lung
viral
clearanc
activ
viru
specif
immun
cell
earli
viru
neutral
antibodi
gener
increas
reduc
immunosuppress
cytokin
product
addit
studi
lung
pig
vaccin
challeng
reduc
microscop
lesion
increas
prolifer
viru
specif
cell
enhanc
product
detect
thu
result
support
favor
antiprrsv
immun
respons
pig
lung
microenviron
mediat
adjuv
mtb
wcl
prrsmlv
